1. Home
  2. OGN vs VRE Comparison

OGN vs VRE Comparison

Compare OGN & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.11

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Veris Residential Inc.

VRE

Veris Residential Inc.

HOLD

Current Price

$18.94

Market Cap

1.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
VRE
Founded
1923
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
OGN
VRE
Price
$6.11
$18.94
Analyst Decision
Hold
Buy
Analyst Count
4
3
Target Price
$11.75
$18.67
AVG Volume (30 Days)
3.0M
2.6M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
1.33%
1.70%
EPS Growth
N/A
420.00
EPS
0.72
0.80
Revenue
$6,216,000,000.00
$288,434,000.00
Revenue This Year
$0.42
N/A
Revenue Next Year
$1.67
$2.87
P/E Ratio
$8.38
$23.62
Revenue Growth
N/A
6.40
52 Week Low
$6.03
$13.69
52 Week High
$15.36
$18.91

Technical Indicators

Market Signals
Indicator
OGN
VRE
Relative Strength Index (RSI) 29.92 79.48
Support Level N/A $14.43
Resistance Level $7.87 N/A
Average True Range (ATR) 0.21 0.04
MACD -0.01 -0.12
Stochastic Oscillator 26.54 76.67

Price Performance

Historical Comparison
OGN
VRE

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

Share on Social Networks: